Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia.
Dickinson
Anne M
AM
Haematological Sciences, Institute of Cellular Medicine, Newcastle University, UK. a.m.dickinson@ncl.ac.uk
Pearce
Kim F
KF
Norden
Jean
J
O'Brien
Stephen G
SG
Holler
Ernst
E
Bickeböller
Heike
H
Balavarca
Yesilda
Y
Rocha
Vanderson
V
Kolb
Hans-Jochem
HJ
Hromadnikova
Ilona
I
Sedlacek
Petr
P
Niederwieser
Dietger
D
Brand
Ronald
R
Ruutu
Tapani
T
Apperley
Jane
J
Szydlo
Richard
R
Goulmy
Els
E
Siegert
Wolfgang
W
de Witte
Theo
T
Gratwohl
Alois
A
D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D016207:Cytokines / Q000235:genetics; D005260:Female; D042822:Genomic Instability; D005838:Genotype; D006086:Graft vs Host Disease / Q000235:genetics / Q000401:mortality; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000401:mortality; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics* / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011446:Prospective Studies; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome; D055815:Young Adult
D016207:Cytokines